RVMDRevolution Medicines, Inc.

$187.03+276% 1Y

Is the price fair?

What RVMD's price assumes

Price / book
15.2

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
15.2
Market capitalisation214.3 million shares, counted Jul 31, 2026
$40.1B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.